{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:32:42Z","timestamp":1678768362824},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00520-023-07617-6","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:19:18Z","timestamp":1677014358000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2\u2014functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Maryam","family":"Lustberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique J.","family":"de Andr\u00e9s-Galiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Leibowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"Suppl 2","key":"7617_CR1","first-page":"S6","volume":"24","author":"G Cavaletti","year":"2019","unstructured":"Cavaletti G et al (2019) Chemotherapy-induced peripheral neurotoxicity: a multifaceted, still unsolved issue. J Peripher Nerv Syst 24(Suppl 2):S6\u2013S12","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"7617_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1188\/19.CJON.405-410","volume":"23","author":"E Autissier","year":"2019","unstructured":"Autissier E (2019) Chemotherapy-induced peripheral neuropathy: association with increased risk of falls and injuries. Clin J Oncol Nurs 23(4):405\u2013410","journal-title":"Clin J Oncol Nurs"},{"issue":"6","key":"7617_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/jnnp-2017-317215","volume":"89","author":"A Shah","year":"2018","unstructured":"Shah A et al (2018) Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort. J Neurol Neurosurg Psychiatry 89(6):636\u2013641","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"7617_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cam4.1256","volume":"7","author":"RE Reinbolt","year":"2018","unstructured":"Reinbolt RE et al (2018) Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm. Cancer Med 7(1):240\u2013253","journal-title":"Cancer Med"},{"issue":"22","key":"7617_CR5","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","volume":"21","author":"BP Schneider","year":"2015","unstructured":"Schneider BP et al (2015) Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199. Clin Cancer Res 21(22):5082\u20135091","journal-title":"Clin Cancer Res"},{"key":"7617_CR6","doi-asserted-by":"crossref","unstructured":"Lustberg M et al (2023) Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer Part 2. Functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer. Support Care in Cancer (In press)","DOI":"10.1007\/s00520-023-07617-6"},{"key":"7617_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-78759-6_3","volume-title":"Sampling defective pathways in phenotype prediction problems via the holdout sampler","author":"JL Fern\u00e1ndez-Mart\u00ednez","year":"2018","unstructured":"Fern\u00e1ndez-Mart\u00ednez JL et al (2018) Sampling defective pathways in phenotype prediction problems via the holdout sampler. Springer International Publishing, Cham"},{"key":"7617_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4137\/CIN.S19745","volume":"13","author":"LN Saligan","year":"2014","unstructured":"Saligan LN et al (2014) Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer. Cancer Inform 13:141\u2013152","journal-title":"Cancer Inform"},{"issue":"3","key":"7617_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/omi.2015.0168","volume":"20","author":"S Ben-Ari Fuchs","year":"2016","unstructured":"Ben-Ari Fuchs S et al (2016) GeneAnalytics: an integrative gene set analysis tool for next generation sequencing. RNAseq and Microarray Data. OMICS 20(3):139\u2013151","journal-title":"RNAseq and Microarray Data. OMICS"},{"key":"7617_CR10","doi-asserted-by":"crossref","unstructured":"Ashburner M et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25\u201329","DOI":"10.1038\/75556"},{"issue":"D1","key":"7617_CR11","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"C The Gene Ontology","year":"2019","unstructured":"The Gene Ontology C (2019) The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res 47(D1):D330\u2013D338","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"7617_CR12","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.\u00a0Proc Natl Acad Sci\u00a0102(43):15545\u201315550","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"7617_CR13","unstructured":"Rodchenkov I et al (2020) Pathway Commons 2019 Update: integration, analysis and exploration of pathway data. Nucleic Acids Res 48(D1):D489\u2013D497"},{"issue":"3","key":"7617_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff JD, Wei Y, Khavari PA (2018) The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 19(3):143\u2013157","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"7617_CR15","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M et al (2014) Incidence, prevalence, and predictors ofchemotherapy-induced peripheral neuropathy: a systematic review andmeta-analysis. Pain 155(12):2461\u201370","journal-title":"Pain"},{"issue":"19","key":"7617_CR16","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-16-3224","volume":"23","author":"ME Dolan","year":"2017","unstructured":"Dolan ME et al (2017) Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer. Clin Cancer Res 23(19):5757\u20135768","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7617_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1186\/s12885-018-4728-4","volume":"18","author":"SH Mahmoudpour","year":"2018","unstructured":"Mahmoudpour SH et al (2018) Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients. BMC Cancer 18(1):820","journal-title":"BMC Cancer"},{"key":"7617_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.critrevonc.2017.09.009","volume":"120","author":"J Cliff","year":"2017","unstructured":"Cliff J et al (2017) The molecular genetics of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Crit Rev Oncol Hematol 120:127\u2013140","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"7617_CR19","first-page":"746","volume":"20","author":"A Leibovici","year":"2018","unstructured":"Leibovici A, Sharon R, Azoulay D (2018) BDNF Val66Met is associated with pre-existing but not with paclitaxel-induced peripheral neuropathy in an Israeli cohort of breast cancer patients. Isr Med Assoc J 20(12):746\u2013748","journal-title":"Isr Med Assoc J"},{"issue":"11","key":"7617_CR20","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/annonc\/mdx491","volume":"28","author":"SB Park","year":"2017","unstructured":"Park SB et al (2017) Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Ann Oncol 28(11):2733\u20132740","journal-title":"Ann Oncol"},{"issue":"4","key":"7617_CR21","first-page":"631","volume":"5","author":"GK Boora","year":"2016","unstructured":"Boora GK et al (2016) Testing of candidate single nucleotide variants associated withpaclitaxel neuropathy in the trial NCCTG N08C1 (Alliance). CancerMed 5(4):631\u20139","journal-title":"CancerMed"},{"issue":"1","key":"7617_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jns.12110","volume":"20","author":"S Terrazzino","year":"2015","unstructured":"Terrazzino S et al (2015) Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis. J Peripher Nerv Syst 20(1):15\u201323","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"7617_CR23","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-13-3232","volume":"20","author":"JE Abraham","year":"2014","unstructured":"Abraham JE et al (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res 20(9):2466\u201375","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7617_CR24","doi-asserted-by":"publisher","first-page":"8789","DOI":"10.1038\/s41598-018-27070-4","volume":"8","author":"CC Reyes-Gibby","year":"2018","unstructured":"Reyes-Gibby CC et al (2018) Genome-wide association study identifies genes associated withneuropathy in patients with head and neck cancer. Sci Rep 8(1):8789","journal-title":"Sci Rep"},{"issue":"2","key":"7617_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.imr.2018.03.006","volume":"7","author":"J Nadipelly","year":"2018","unstructured":"Nadipelly J et al (2018) Effect of certain trimethoxy flavones on paclitaxel - inducedperipheral neuropathy in mice. Integr Med Res 7(2):159\u2013167","journal-title":"Integr Med Res"},{"key":"7617_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.biopha.2017.09.108","volume":"95","author":"M Shahid","year":"2017","unstructured":"Shahid M et al (2017) Theflavonoid 6-methoxyflavone allays cisplatin-induced neuropathicallodynia and hypoalgesia. Biomed Pharmacother 95:1725\u20131733","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"7617_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/antiox9100973","volume":"9","author":"TL Suraweera","year":"2020","unstructured":"Suraweera TL et al (2020) Regulation of Nrf2\/ARE pathway by dietary flavonoids: a friend or foe for cancer management? Antioxidants (Basel) 9(10):973. https:\/\/doi.org\/10.3390\/antiox9100973","journal-title":"Antioxidants (Basel)"},{"issue":"19","key":"7617_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/FPC.0b013e3283335277","volume":"2009","author":"C Oshiro","year":"2009","unstructured":"Oshiro C et al (2009) Taxanepathway. Pharmacogenet Genomics 2009(19):979\u201383","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"7617_CR29","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1158\/1078-0432.CCR-04-1254","volume":"11","author":"J Yu","year":"2005","unstructured":"Yu J et al (2005) Geneexpression profiling of the irinotecan pathway in colorectal cancer. Clin Cancer Res 11(5):2053\u20132062","journal-title":"Clin Cancer Res"},{"issue":"38","key":"7617_CR30","doi-asserted-by":"publisher","first-page":"25355","DOI":"10.18632\/oncotarget.25256","volume":"9","author":"R Palmirotta","year":"2018","unstructured":"Palmirotta R et al (2018) SNPs in predicting clinical efficacy and toxicity of chemotherapy:walking through the quicksand. Oncotarget 9(38):25355\u201325382","journal-title":"Oncotarget"},{"issue":"7","key":"7617_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tig.2018.03.005","volume":"34","author":"UM Marigorta","year":"2018","unstructured":"Marigorta UM et al (2018) Replicability and Prediction: Lessons and Challenges from GWAS. Trends Genet 34(7):504\u2013517","journal-title":"Trends Genet"},{"issue":"8","key":"7617_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam V et al (2019) Benefitsand limitations of genome-wide association studies. Nat Rev Genet 20(8):467\u2013484","journal-title":"Nat Rev Genet"},{"key":"7617_CR33","doi-asserted-by":"crossref","unstructured":"Chung R-H, Kang C-Y (2019) A multi-omics data simulator for complex disease studies and\nits application to evaluate multi-omics data analysis methods for\ndisease classification. GigaScience 8(5)","DOI":"10.1093\/gigascience\/giz045"},{"issue":"3","key":"7617_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/comnet\/cnu016","volume":"2","author":"M Kivel\u00e4","year":"2014","unstructured":"Kivel\u00e4 M et al (2014) Multilayer networks. J Complex Netw 2(3):203\u2013271","journal-title":"J Complex Netw"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07617-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T06:08:06Z","timestamp":1678687686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7617"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07617-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"16 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines and approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"It was previously approved by ethics, and patients were consented for participation and analysis of correlative data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors consented to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Sonis reports personal fees from Biomodels, LLC, and personal fees from Primary Endpoint Solutions, LLC, outside of the submitted work. As an employee of Biomodels and PES, he is involved in assisting industry, government, and academics in the study and enablement of drugs, biologicals, and devices to treat patients for a broad range of indications including cancer and toxicities of cancer therapy. He does not have equity or receive payment from any of the companies\u2019 clients. The other authors have no relevant disclosers.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"178"}}